Just when I thought the issues with Xeloda were resolved, I am told that my prescription is on hold until I provide signed acknowledgment of notification of a change in the Roche Foundation.
In March 2009, Roche and Genentech became one company and this led to some changes. As of December 31 2009, Roche ceased to distribute free medicine. Starting January 01 2010, I have the option to be supported by the Genentech Access To Care Foundation, which will provide access to Roche products previously provided by the Roche Foundation. This notification was mailed out on January 04 2010.
In order to transition with no interruption in my medical treatments, I need to sign and return the GATCF Patient Authorization and Notice of Release of Information (PAN) form that will be provided to me. They are supposed to have included a self-address, stamped envelope for convenience. That was very nice consideration.
Thankfully, the prescription was extended for this month, and these limits won’t be effective til next month. As soon as I receive the forms, I will fill them out and return them!
I hope this change does not effect my Genentech PAP for Tarceva and I can’t afford to loose my Xeloda PAP either.
A state of constant flux and I’m back on the roller coaster…
